Higher Risk Myelodysplastic Syndromes in Patients with Well-Controlled HIV Infection: Clinical Features, Treatment, and Outcome

<div>Clinical course of a patient presenting with higher IPSS risk MDS in the context of well-controlled HIV infection. AIM: autoimmune manifestations; AML: acute myeloid leukemia; AZA: azacitidine; IPSS: International Prognostic Scoring System; MDS: myelodysplastic syndrome.</div>

Case Reports in Hematology

fig1

Figure 1

Figure 1: Higher Risk Myelodysplastic Syndromes in Patients with Well-Controlled HIV Infection: Clinical Features, Treatment, and Outcome 